Processing

Please wait...

Settings

Settings

1. WO1996004559 - METHOD FOR SEPARATING AND/OR SCREENING AND/OR QUANTIFYING ONE OR MORE INFECTIOUS COMPOUNDS AND SUPPORT FOR IMPLEMENTING SAID METHOD

Publication Number WO/1996/004559
Publication Date 15.02.1996
International Application No. PCT/FR1995/001032
International Filing Date 31.07.1995
Chapter 2 Demand Filed 07.12.1995
IPC
G01N 33/569 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
569for microorganisms, e.g. protozoa, bacteria, viruses
G01N 33/576 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
576for hepatitis
CPC
G01N 33/569
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
569for microorganisms, e.g. protozoa, bacteria, viruses
G01N 33/56983
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
569for microorganisms, e.g. protozoa, bacteria, viruses
56983Viruses
G01N 33/56988
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
569for microorganisms, e.g. protozoa, bacteria, viruses
56983Viruses
56988AIDS or HTLV
G01N 33/5761
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
576for hepatitis
5761Hepatitis B
Y02A 50/55
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
50in human health protection
30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
50Chemical or biological analysis of biological material for identifying the disease, e.g. blood or urine testing, rapid diagnostic tests [RTDs] or immunological testing
55the disease being Leishmaniasis, Sand-fly fever, phlebotomus fever, kala-azar, black fever or Dumdum fever
Applicants
  • INSTITUT FRANÇAIS DE RECHERCHES SCIENTIFIQUES POUR LE DEVELOPPEMENT EN COOPERATION - ORSTOM [FR/FR]; 213, rue La Fayette F-75010 Paris, FR (AllExceptUS)
  • STEFAS, Elie [FR/FR]; FR (UsOnly)
  • RUCHETON, Marcel [FR/FR]; FR (UsOnly)
  • GRAAFLAND, Hubert [FR/FR]; FR (UsOnly)
Inventors
  • STEFAS, Elie; FR
  • RUCHETON, Marcel; FR
  • GRAAFLAND, Hubert; FR
Agents
  • PEUSCET, Jacques; Cabinet Peuscet et Autres 68, rue d'Hauteville F-75010 Paris, FR
Priority Data
94/0952801.08.1994FR
94/0952901.08.1994FR
Publication Language French (FR)
Filing Language French (FR)
Designated States
Title
(EN) METHOD FOR SEPARATING AND/OR SCREENING AND/OR QUANTIFYING ONE OR MORE INFECTIOUS COMPOUNDS AND SUPPORT FOR IMPLEMENTING SAID METHOD
(FR) PROCEDE DE SEPARATION ET/OU DE DETECTION ET/OU DE QUANTIFICATION DE COMPOSE(S) INFECTIEUX ET SUPPORT POUR LA MISE EN ×UVRE DU PROCEDE
Abstract
(EN)
Method for separating and/or screening and/or quantifying one or more infectious compounds (IC) in a biological material, characterised in that a $g(b)2GPI/IC complex, chosen from the group comprising a) ($g(b)2GPI)n/IC complexes and b) ($g(b)2GPI)r/nVIC (non viral IC) complexes, is separated and/or screened and/or quantified.
(FR)
L'invention concerne un procédé de séparation et/ou de détection et/ou de quantification de composés infectieux (CI) dans un matériau biologique, caractérisé par le fait que l'on sépare et/ou détecte et/ou quantifie un complexe $g(b)2GPI/CI pris dans le groupe formé par: a) les complexes ($g(b)2GPI)n/CI, b) les complexes ($g(b)2GPI)r/CInV.
Also published as
Latest bibliographic data on file with the International Bureau